Related references
Note: Only part of the references are listed.Noninfectious Pulmonary Complications after Hematopoietic Stem Cell Transplantation: Practical Approach to Imaging Diagnosis
Elena Pena et al.
RADIOGRAPHICS (2014)
Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation
Frederic Schlemmer et al.
RESPIRATORY MEDICINE (2014)
Risk Factors and Outcome of Pulmonary Complications After Autologous Hematopoietic Stem Cell Transplant
Bekele Afessa et al.
CHEST (2012)
Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: Incidence, all-cause mortality and characteristics at diagnosis
Rajeev K. Amar et al.
RESPIROLOGY (2012)
Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis
Elizabeth F. Redente et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
An Official American Thoracic Society Research Statement: Noninfectious Lung Injury after Hematopoietic Stem Cell Transplantation: Idiopathic Pneumonia Syndrome
Angela Panoskaltsis-Mortari et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
High-dose busulfan and the risk of pulmonary mortality after autologous stem cell transplant
Matt Kalaycio et al.
CLINICAL TRANSPLANTATION (2006)
Incidence and outcome of idiopathic pneumonia syndrome in pediatric stem cell transplant recipients
J. Keates-Baleeiro et al.
BONE MARROW TRANSPLANTATION (2006)
Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib
M Ando et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial
F Berthold et al.
LANCET ONCOLOGY (2005)
High dose melphalan in the treatment of advanced neuroblastoma: Results of a randomised trial (ENSG-1) by the European neuroblastoma study group
J Pritchard et al.
PEDIATRIC BLOOD & CANCER (2005)
Involvement of pulmonary endothelial cell injury in the pathogenesis of pulmonary fibrosis:: clinical assessment by 123I-MIBG lung scintigraphy
N Takabatake et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation
F Patriarca et al.
BONE MARROW TRANSPLANTATION (2004)
Interstitial lung disease induced by drugs and radiation
P Camus et al.
RESPIRATION (2004)
Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation
T Fukuda et al.
BLOOD (2003)
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis
PA Meyers et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Megatherapy combining I131 metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma
M Miano et al.
BONE MARROW TRANSPLANTATION (2001)
Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation
MS Akasheh et al.
BONE MARROW TRANSPLANTATION (2000)
Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support
KS Bhalla et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation
TM Cao et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Share Paper
